NextGen Healthcare Inc. (NXGN)
NASDAQ: NXGN
· Real-Time Price · USD
23.94
0.03 (0.13%)
At close: Nov 08, 2023, 10:00 PM
NextGen Healthcare Revenue Breakdown
| Period Ending | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 |
|---|---|---|---|---|---|
| Managed Services Revenue | 129.12M | 116.72M | 103.14M | 104.55M | 98.2M |
| Managed Services Revenue Growth | +10.62% | +13.17% | -1.35% | +6.46% | n/a |
| Other Non Recurring Services Revenue | 31.39M | 25.29M | 25.18M | 23.66M | 20.13M |
| Other Non Recurring Services Revenue Growth | +24.14% | +0.45% | +6.43% | +17.52% | n/a |
| Recurring Revenue Revenue | 593.92M | 539.71M | 502.82M | 489.31M | 473.92M |
| Recurring Revenue Revenue Growth | +10.04% | +7.34% | +2.76% | +3.25% | n/a |
| Software Hardware And Other Non Recurring Revenue | 59.25M | 56.64M | 54M | 50.93M | 55.25M |
| Software Hardware And Other Non Recurring Revenue Growth | +4.62% | +4.88% | +6.04% | -7.83% | n/a |
| Software License And Hardware Revenue | 27.86M | 31.35M | 28.82M | 27.27M | 35.12M |
| Software License And Hardware Revenue Growth | -11.12% | +8.75% | +5.70% | -22.36% | n/a |
| Subscription Services Revenue | 184.05M | 162.64M | 148.4M | 127.6M | 117.5M |
| Subscription Services Revenue Growth | +13.16% | +9.59% | +16.30% | +8.60% | n/a |
| Support And Maintenance Revenue | 153.52M | 155.62M | 152.96M | 158.62M | 160.8M |
| Support And Maintenance Revenue Growth | -1.35% | +1.74% | -3.57% | -1.36% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 54.17M | 48.19M | 83.33M | 46.18M | 44.89M | 49.03M | 50.05M | 47.24M | 63.89M | 48.49M | 48.87M | 48.97M | 41.95M | 40.74M | 43.16M | 42.84M | 39.05M | 40.13M | 44.71M | 41.3M | 34.23M | 44.64M | 65.71M | 43.56M | 40.98M | 42.98M | 42.71M | 37.54M | 42.79M | 40.58M | 40.27M | 39.4M | 37.4M | 39.17M | 41.28M |
| Selling, General, and Administrative Revenue Growth | +12.41% | -42.16% | +80.45% | +2.88% | -8.46% | -2.02% | +5.94% | -26.06% | +31.77% | -0.79% | -0.21% | +16.74% | +2.98% | -5.61% | +0.74% | +9.72% | -2.70% | -10.25% | +8.25% | +20.67% | -23.32% | -32.07% | +50.84% | +6.31% | -4.65% | +0.63% | +13.77% | -12.26% | +5.44% | +0.77% | +2.23% | +5.35% | -4.53% | -5.11% | n/a |
| Research and Development Revenue | 18.02M | 20.93M | 20.03M | 19.62M | 20.86M | 21.8M | 19.43M | 19.39M | 18.52M | 19.32M | 21.39M | 18.2M | 17.69M | 18.22M | 21.43M | 20.03M | 19.79M | 22.05M | 19.81M | 20.68M | 18.37M | 22.13M | 21.1M | 20.64M | 19.53M | 19.99M | 22.11M | 19.71M | 18.29M | 18.22M | 16.08M | 14.52M | 17.98M | 17.09M | 17.64M |
| Research and Development Revenue Growth | -13.88% | +4.48% | +2.07% | -5.93% | -4.30% | +12.18% | +0.20% | +4.71% | -4.16% | -9.67% | +17.55% | +2.85% | -2.91% | -14.97% | +7.01% | +1.20% | -10.26% | +11.30% | -4.20% | +12.58% | -16.98% | +4.88% | +2.19% | +5.73% | -2.31% | -9.60% | +12.16% | +7.77% | +0.37% | +13.35% | +10.74% | -19.26% | +5.24% | -3.14% | n/a |